[HTML][HTML] The opioid exposed newborn: assessment and pharmacologic management
LM Jansson, M Velez, C Harrow - Journal of opioid management, 2009 - ncbi.nlm.nih.gov
The infant exposed to opioids in utero frequently presents a challenge to the neonatal care
provider in the assessment and treatment of symptoms of Neonatal Abstinence Syndrome …
provider in the assessment and treatment of symptoms of Neonatal Abstinence Syndrome …
Review of the assessment and management of neonatal abstinence syndrome
SM Bagley, EM Wachman, E Holland… - Addiction science & …, 2014 - Springer
Neonatal abstinence syndrome (NAS) secondary to in-utero opioid exposure is an
increasing problem. Variability in assessment and treatment of NAS has been attributed to …
increasing problem. Variability in assessment and treatment of NAS has been attributed to …
Managing drug withdrawal in the newborn infant
C Kuschel - Seminars in Fetal and Neonatal Medicine, 2007 - Elsevier
The management of the infant exposed to drugs in utero poses significant challenges.
Symptoms and signs of neonatal abstinence syndrome (NAS) are non-specific but most …
Symptoms and signs of neonatal abstinence syndrome (NAS) are non-specific but most …
Neonatal abstinence syndrome: review of epidemiology, care models, and current understanding of outcomes
KDL MacMillan - Clinics in perinatology, 2019 - perinatology.theclinics.com
Background Neonatal abstinence syndrome (NAS) includes an array of symptoms impacting
opioid-exposed newborns (OEN) owing to postnatal withdrawal from in utero substance …
opioid-exposed newborns (OEN) owing to postnatal withdrawal from in utero substance …
Current management of neonatal abstinence syndrome secondary to intrauterine opioid exposure
JR Wiles, B Isemann, LP Ward, AA Vinks… - The Journal of …, 2014 - jpeds.com
Neonatal abstinence syndrome (NAS) comprises a constellation of drug-withdrawal
symptoms that result from chronic intrauterine exposure to a variety of substances, including …
symptoms that result from chronic intrauterine exposure to a variety of substances, including …
Neonatal abstinence syndrome
K McQueen, J Murphy-Oikonen - New England Journal of …, 2016 - Mass Medical Soc
Neonatal Abstinence Syndrome | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
Neonatal opioid withdrawal syndrome
MB Sutter, L Leeman, A Hsi - Obstetrics and Gynecology …, 2014 - obgyn.theclinics.com
Neonates who have had in utero exposures from maternal substance abuse can experience
central nervous system effects of the drugs, including drug toxicity and withdrawal. Neonatal …
central nervous system effects of the drugs, including drug toxicity and withdrawal. Neonatal …
Pharmacologic management of the opioid neonatal abstinence syndrome
WK Kraft, JN van den Anker - Pediatric Clinics, 2012 - pediatric.theclinics.com
Neonatal withdrawal symptoms have been noted following prenatal exposure to several
drugs. Examples include opioids, 1, 2 benzodiazepines, 3, 4 mood-stabilizing medications …
drugs. Examples include opioids, 1, 2 benzodiazepines, 3, 4 mood-stabilizing medications …
Neonatal abstinence syndrome: advances in diagnosis and treatment
Importance Neonatal abstinence syndrome, which occurs as a result of in utero opioid
exposure, affects between 6.0 and 20 newborns per 1000 live US births. There is substantial …
exposure, affects between 6.0 and 20 newborns per 1000 live US births. There is substantial …
Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey
S Sarkar, SM Donn - Journal of Perinatology, 2006 - nature.com
Aims: To determine the monitoring and treatment of neonatal abstinence syndrome (NAS) in
neonatal intensive care units (NICUs) following opiate or polydrug exposure in utero …
neonatal intensive care units (NICUs) following opiate or polydrug exposure in utero …